Erciyes Üniversitesi Tıp Fakültesi Hakan Çetinsaya DEKAM’da gerçekleştirilen
“Sıçanlarda oluşturulan deneysel intestinal iskemi reperfüzyon modelinde Quercitrin’in etkileri” adlı çalışmanın sonuçları şu şekilde sıralanabilir:
1. Histolojik olarak Quercitrin’in iskemi sonrası reperfüzyona bağlı intestinal mukoza hasarını azaltıcı etkisi mevcuttur.
2. Bu çalışma da MDA, NO ve 8-OHdG aktivitelerinde ki azalmanın Quercitrin’in oksidatif stres üzerinde önleyici etkisini göstermektedir.
3. Quercitrin’in SOD ve GSH-Px gibi vücudun doğal antioksidanların üzerinde bir etkiye sahip değildir.
47
KAYNAKLAR
1. İlgi, Gastrointestinal sistem anatomisi. Temel Cerrahi (3. baskı), 2004. 1015-1024.
2. Wyers, M.C., Acute mesenteric ischemia: diagnostic approach and surgical treatment. Semin Vasc Surg. 23(1): p. 9-20.
3. Schoots, I.G., et al., Thrombolytic therapy for acute superior mesenteric artery occlusion. J Vasc Interv Radiol, 2005. 16(3): p. 317-29.
4. Dahlke, M.H., et al., Mesenteric ischemia--outcome after surgical therapy in 83 patients. Dig Surg, 2008. 25(3): p. 213-9.
5. Zimmerman, B.J. and D.N. Granger, Reperfusion injury. Surg Clin North Am, 1992. 72(1): p. 65-83.
6. Wilhelm, J., Metabolic aspects of membrane lipid peroxidation. Acta Univ Carol Med Monogr, 1990. 137: p. 1-53.
7. Mallick, I.H., et al., Ischemia-reperfusion injury of the intestine and protective strategies against injury. Dig Dis Sci, 2004. 49(9): p. 1359-77.
8. Bobadilla, J.L., Mesenteric ischemia. Surg Clin North Am. 93(4): p. 925-40, ix.
9. Yasuhara, H., Acute mesenteric ischemia: the challenge of gastroenterology. Surg Today, 2005. 35(3): p. 185-95.
10. Klar, E., et al., Acute mesenteric ischemia: a vascular emergency. Dtsch Arztebl Int. 109(14): p. 249-56.
11. Sise, M.J., Acute mesenteric ischemia. Surg Clin North Am. 94(1): p. 165-81.
12. Townsend, Sabiston Textbook of Surgery (17th ed.). Saunders Company, 2004.
p.24.
13. Douard, Clinical interest of digestive arterial trunk anastomoses. Surg Radiol Anat. 28(3):219-27., 2006. 28(3): p. 219-27.
14. Fischer, Mastery of Surgery (5th ed.) Lippincott Williams & Wilkins, 2007: p.
821.
48
15. Bathe, O.F., A.W. Chow, and P.T. Phang, Splanchnic origin of cytokines in a porcine model of mesenteric ischemia-reperfusion. Surgery, 1998. 123(1): p. 79-88.
16. Jennings, R.B. and K.A. Reimer, The cell biology of acute myocardial ischemia.
Annu Rev Med, 1991. 42: p. 225-46.
17. Green, C.J., et al., The importance of iron, calcium and free radicals in reperfusion injury: an overview of studies in ischaemic rabbit kidneys. Free Radic Res Commun, 1989. 7(3-6): p. 255-64.
18. Orrenius, S., et al., Calcium ions and oxidative cell injury. Ann Neurol, 1992. 32 Suppl: p. S33-42.
19. Terzi, sıçanlarda intestinal iskemi modelinde proflaktik kısa ve uzun süreli doz allopurinol kullanımının mortalitiye etkisi. klinik ve deneysel cerahi dergisi, 2000.
9: p. 10-16.
20. Bilbao, G., et al., Reduction of ischemia-reperfusion injury of the liver by in vivo adenovirus-mediated gene transfer of the antiapoptotic Bcl-2 gene. Ann Surg, 1999. 230(2): p. 185-93.
21. Parks, Ischemia-induced vascular changes: role of xanthine oxidase and hydroxyl radicals. Am J Physiol 1983. 245: p. 285-289.
22. Schoenberg, M.H. and H.G. Beger, Reperfusion injury after intestinal ischemia.
Crit Care Med, 1993. 21(9): p. 1376-86.
23. Molnar, Z., E. Shearer, and D. Lowe, N-Acetylcysteine treatment to prevent the progression of multisystem organ failure: a prospective, randomized, placebo-controlled study. Crit Care Med, 1999. 27(6): p. 1100-4.
24. Savas, C., et al., Pentoxifylline inhibits overflow and reduces intestinal reperfusion injury. J Pediatr Surg, 1997. 32(6): p. 905-10.
25. Mustafa, N.A., et al., Role of diltiazem in ischemia-reperfusion injury of the intestine. Eur Surg Res, 1994. 26(6): p. 335-41.
26. Grace, ischaemia-reperfusion injury. british j of surgery, 1994. 81: p. 637-647.
27. Günel, Treatment of intestinal reperfusion injury using antioxidative agents.
pediatr surg, 1998. 33: p. 1536-1539.
49
28. Reilly, P.M., H.J. Schiller, and G.B. Bulkley, Pharmacologic approach to tissue injury mediated by free radicals and other reactive oxygen metabolites. Am J Surg, 1991. 161(4): p. 488-503.
29. Parks, D.A., et al., Soybean trypsin inhibitor attenuates ischemic injury to the feline small intestine. Gastroenterology, 1985. 89(1): p. 6-12.
30. Haglund, U. and D. Bergqvist, Intestinal ischemia -- the basics. Langenbecks Arch Surg, 1999. 384(3): p. 233-8.
31. Ormrod, D.J., G.L. Harrison, and T.E. Miller, Inhibition of neutrophil myeloperoxidase activity by selected tissues. J Pharmacol Methods, 1987. 18(2):
p. 137-42.
32. Zimmerman, B.J. and D.N. Granger, Mechanisms of reperfusion injury. Am J Med Sci, 1994. 307(4): p. 284-92.
33. stojadinovib, Anti-inflammatory effects of U743S9F in a rat model of intestinal ischemia-reperfision injury. crit care med, 1999. 27: p. 764-770.
34. Conner, W.C., et al., Neutrophil priming state predicts capillary leak after gut ischemia in rats. J Surg Res, 1999. 84(1): p. 24-30.
35. Halliwell, B., Free radicals, antioxidants, and human disease: curiosity, cause, or consequence? Lancet, 1994. 344(8924): p. 721-4.
36. Tamer, serbest radikaller. MEÜ, 2000. 1: p. 52-58.
37. Akkuş, serbest radikaller ve fizyopatolojik etkileri. mimoza yayınları, 1995: p. 1-80.
38. Weiss, S.J. and A.F. LoBuglio, Phagocyte-generated oxygen metabolites and cellular injury. Lab Invest, 1982. 47(1): p. 5-18.
39. McCord, oxygen derived free radicalsin postischemic tissue injury. N engl J Med, 1985. jan 17: p. 159-163.
40. Poole, J.W., R.J. Sammartano, and S.J. Boley, Hemodynamic basis of the pain of chronic mesenteric ischemia. Am J Surg, 1987. 153(2): p. 171-6.
41. Furchgott, R.F. and J.V. Zawadzki, The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature, 1980. 288(5789): p.
373-6.
50
42. Ignarro, L.J., et al., Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide. Proc Natl Acad Sci U S A, 1987. 84(24): p.
9265-9.
43. Palmer, R.M., A.G. Ferrige, and S. Moncada, Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature, 1987.
327(6122): p. 524-6.
44. Moncada, S., R.M. Palmer, and E.A. Higgs, Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev, 1991. 43(2): p. 109-42.
45. Luscher, T.F., Endogenous and exogenous nitrates and their role in myocardial ischaemia. Br J Clin Pharmacol, 1992. 34 Suppl 1: p. 29S-35S.
46. Bassenge, E., Clinical relevance of endothelium-derived relaxing factor (EDRF).
Br J Clin Pharmacol, 1992. 34 Suppl 1: p. 37S-42S.
47. kalpaklıoğlu, nitrik oksit. MN, 1996. 4/2: p. 88-90.
48. Beckman, J.S., et al., Apparent hydroxyl radical production by peroxynitrite:
implications for endothelial injury from nitric oxide and superoxide. Proc Natl Acad Sci U S A, 1990. 87(4): p. 1620-4.
49. Radi, R., et al., Peroxynitrite-induced membrane lipid peroxidation: the cytotoxic potential of superoxide and nitric oxide. Arch Biochem Biophys, 1991. 288(2): p.
481-7.
50. Stark, M.E. and J.H. Szurszewski, Role of nitric oxide in gastrointestinal and hepatic function and disease. Gastroenterology, 1992. 103(6): p. 1928-49.
51. Clancy, R.M., J. Leszczynska-Piziak, and S.B. Abramson, Nitric oxide, an endothelial cell relaxation factor, inhibits neutrophil superoxide anion production via a direct action on the NADPH oxidase. J Clin Invest, 1992. 90(3): p. 1116-21.
52. Efron, D.T., et al., Nitric oxide generation from L-arginine is required for optimal human peripheral blood lymphocyte DNA synthesis. Surgery, 1991. 110(2): p.
327-34.
53. Ochoa, J.B., et al., Nitrogen oxide levels in patients after trauma and during sepsis. Ann Surg, 1991. 214(5): p. 621-6.
51
54. Petros, A., D. Bennett, and P. Vallance, Effect of nitric oxide synthase inhibitors on hypotension in patients with septic shock. Lancet, 1991. 338(8782-8783): p.
1557-8.
55. Park, J.H., et al., Protective effect of nitric oxide in an endotoxin-induced septic shock. Am J Surg, 1996. 171(3): p. 340-5.
56. Ignarro, L.J., et al., Oxidation of nitric oxide in aqueous solution to nitrite but not nitrate: comparison with enzymatically formed nitric oxide from L-arginine. Proc Natl Acad Sci U S A, 1993. 90(17): p. 8103-7.
57. Kondo, K., et al., Simultaneous measurement of endothelium-derived relaxing factor by bioassay and guanylate cyclase stimulation. Br J Pharmacol, 1989.
98(2): p. 630-6.
58. Hecker, M., et al., Endothelial cells metabolize NG-monomethyl-arginine to L-citrulline and subsequently to L-arginine. Biochem Biophys Res Commun, 1990.
167(3): p. 1037-43.
59. Muller, C.D. and F. Schuber, Fluorometric determination of polystyrene latex:
application to the measurement of phagosomes and phagocytosis. Anal Biochem, 1986. 152(1): p. 167-71.
60. Pai, use of chemiluminescence detector for quantitation of nitric oxide produced in assays of denitrifying enzymes. anal. biochem, 1987. 166: p. 150-7.
61. Green, analysis of nitrate,nitrit and nitrate in biological fluids. Anal. biochem, 1982. 126: p. 131-8.
62. granger, determination of nitrate and nitriti in biological samples using bacterial nitrate reductase coupled with the griess reaction. methods enzmology, 1996. 268:
p. 142-51.
63. Aydıner, deneysel testis torsiyonunda doku hasarının önlenmesinde Nasetilsisteinin rolü Trakya Üni., 2005.
64. Cui, K., et al., Role of oxidative stress in neurodegeneration: recent developments in assay methods for oxidative stress and nutraceutical antioxidants. Prog Neuropsychopharmacol Biol Psychiatry, 2004. 28(5): p. 771-99.
65. Shah, P.C., et al., Effect of aging on intestinal ischemia and reperfusion injury.
Mech Ageing Dev, 1999. 107(1): p. 37-50.
52
66. Hirayama, K., A. Yasutake, and M. Inoue, Free radicals and trace elements. Prog Clin Biol Res, 1993. 380: p. 257-68.
67. Bird, R.P. and H.H. Draper, Comparative studies on different methods of malonaldehyde determination. Methods Enzymol, 1984. 105: p. 299-305.
68. Baykal Y., K.F., Serbest radikaller ve hücre hasarı. sendrom, 2000. 9: p. 31-39.
69. Onur, DNA hasarı ve onarım mekanizmaları. 2009. 7/2: p. 61.
70. Prabhulkar, S. and C.Z. Li, Assessment of oxidative DNA damage and repair at single cellular level via real-time monitoring of 8-OHdG biomarker. Biosens Bioelectron. 26(4): p. 1743-9.
71. Halliwell, B. and O.I. Aruoma, DNA damage by oxygen-derived species. Its mechanism and measurement in mammalian systems. FEBS Lett, 1991. 281(1-2):
p. 9-19.
72. Dizdaroglu, M., et al., Free radical-induced damage to DNA: mechanisms and measurement. Free Radic Biol Med, 2002. 32(11): p. 1102-15.
73. Dizdaroglu, M., Oxidatively induced DNA damage: mechanisms, repair and disease. Cancer Lett. 327(1-2): p. 26-47.
74. Harri, M., et al., Analysis of 8-hydroxy-2'-deoxyguanosine in urine using high-performance liquid chromatography-electrospray tandem mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci, 2007. 853(1-2): p. 242-6.
75. Wu, L.L., et al., Urinary 8-OHdG: a marker of oxidative stress to DNA and a risk factor for cancer, atherosclerosis and diabetics. Clin Chim Acta, 2004. 339(1-2):
p. 1-9.
76. E., A., oksidatif DNA hasarı ve kromatografik yöntemlerle tespit edilmesi. YYU veteriner fakültesi dergisi, 2009. 20(2): p. 79-83.
77. Valavanidis, A., T. Vlachogianni, and C. Fiotakis, 8-hydroxy-2' -deoxyguanosine (8-OHdG): A critical biomarker of oxidative stress and carcinogenesis. J Environ Sci Health C Environ Carcinog Ecotoxicol Rev, 2009. 27(2): p. 120-39.
78. chen, 8-hydroxy-2-deoxyguanosine in leukocyte DNA of spermatic vein as a biomarker of oxidative stress in patients with varicocele. journal of urology, 2004.
172: p. 1418-21.
53
79. Hu, C.W., M.R. Chao, and C.H. Sie, Urinary analysis of 8-oxo-7,8-dihydroguanine and 8-oxo-7,8-dihydro-2'-deoxyguanosine by isotope-dilution LC-MS/MS with automated solid-phase extraction: Study of 8-oxo-7,8-dihydroguanine stability. Free Radic Biol Med. 48(1): p. 89-97.
80. Halliwell, B. and J.M. Gutteridge, The antioxidants of human extracellular fluids.
Arch Biochem Biophys, 1990. 280(1): p. 1-8.
81. girotti, lipit hydroperoxide generation,turnover and effector action in biological systems. j lipit res, 2000. 39: p. 1529-1542.
82. T,E., kan malondialdehid ve total antioksidan seviyesinin önemi. cerrahi tıp bülteni, 2001. 2: p. 154-167.
83. Haga, S., et al., Hepatic ischemia induced immediate oxidative stress after reperfusion and determined the severity of the reperfusion-induced damage.
Antioxid Redox Signal, 2009. 11(10): p. 2563-72.
84. akkuş, serbest radikaller ve fizyopatolojik etkileri. Mimoza yayınları, 2000: p. 1-124.
85. Chen, H.F. and Y.R. Kou, Vagal and mediator mechanisms underlying the tachypnea caused by pulmonary air embolism in dogs. J Appl Physiol (1985), 2000. 88(4): p. 1247-53.
86. Kutty, R.K., et al., Induction of heme oxygenase 1 in the retina by intense visible light: suppression by the antioxidant dimethylthiourea. Proc Natl Acad Sci U S A, 1995. 92(4): p. 1177-81.
87. Nına fabjan, j.r., ıztok joze kosır, zhuanhua wang, and ı.k. Zheng zhang, Tartary Buckwheat (Fagopyrum tataricum Gaertn.) as a Source of Dietary Rutin and Quercitrin. American Chemical Society, 2003.
88. Moskaug, J.O., Molecular imaging of the biological effects of quercetin and quercetin-rich foods. Mech Ageing Dev, 2004. 125(4): p. 315-24.
89. Nackz, phenolics in cereals, fruits and vegetables: Oceurrence, Extraction and analysis. Journal Pharmaceutical and biomedical analysis, 2006. 21: p. 1523-42.
90. stavric, Role of chemopreventers in human diet. Clin Biochem, 1994. 27: p. 319-332.
54
91. formica, Review of the biology of Quercetin and related bioflavonoids. Food Chem Toxicol, 1995. 33(12): p. 1061-80., 1995. 33: p. 1061-80.
92. Bors, Flavonoids as antioxidants: determination of radical-scavenging efficiencies. Methods Enzymol, 1990. 186: p. 343-55.
93. Skaper, Quercetin protects cutaneous tissue-associated cell types including sensory neurons from oxidative stress induced by glutathione depletion:
cooperative effects of ascorbic acid. . Free Radic Biol Med, 1997. 22: p. 669-78.
94. Hertog, Dietary antioxidant flavonoids and risk of coronary heart disease: the Zutphen Elderly Study. Lancet, 1993. 342: p. 1007-11.
95. Cao, Antioxidant and prooxidant behavior of flavonoids: structure-activity relationships. . Free Radic Biol Med, 1997. 22: p. 749-60.
96. grylewski, On the mechanism of antithrombotic action of flavonoids. . Biochem Pharmacol, 1987. 36: p. 317-22.
97. Medina, S.d., Effect of quercitrin on the early stages of hapten induced colonic inflammation in the rat. Life Sci, 2002. 70: p. 3098-108.
98. Hai-dong, sulforafhane protects liver injury induced by intestinal ischemia reperfusion through nrf2-are pathway. world j gastroenterol, 2010. 28: p. 3002-10.
99. Chiu, C.J., et al., Intestinal mucosal lesion in low-flow states. I. A morphological, hemodynamic, and metabolic reappraisal. Arch Surg, 1970. 101(4): p. 478-83.
100. Yagi, MethodsEnzymol AcademicPress,, 1984. 105: p. 328-31.
101. Ohkawa, Assayforlipidperoxides in animaltissuesbythiobarbituricacidreaction. . Anal Biochem, 1979. 95: p. 351-58.
102. Bradford, rapidandsensitivemethodforthequantitation of microgramquantities of protein utilizingthepriniple of protein–dyebinding. . Anal Biochem, 1976. 72: p.
248-254.
103. W, T., Ischaemia and infarction. Genel Pathology Seventh Edition, 1996. 709-722.
104. Kazez, the role of melatonin in prevention of intestinal ischemia-reperfusion injury in rats. journal of pediatirc surgery, 2000. 35: p. 1444-1448.
55
105. Şener, the effect of pentoxifylline on intestinal ischemia/reperfusion injury.
blackwell science fundemental, 2001. 15(19-22).
106. Günel, treatment of intestinal reperfusion injury using antioxidative agents.
journal of pediatirc surgery, 1998. 33: p. 1536-1539.
107. acworth, reactive oxygen species massachusetts, 1997: p. 1-4.
108. Mallick, ischemia-reperfusion injury of the intestine and protective strategies against injury. dis sci, 2004. 49: p. 1359-1377.
109. Mallick, pyrrolidine dithiocarbamate reduces ischemia-reperfusion injury of the small intestine. world j gastroenterol, 2005. 11: p. 7308-7313.
110. Camuesco, the intestinal anti-inflammatory effect of quercitrin is associated with an inhibition in iNOS expression. Br J Pharmacol, 2004. 143: p. 908-18.
111. Y, H., The correlation between active oxygens scavenging and antioxidative effects of flavonoids. Free Rad. Bio!. Med, 1994. 16: p. 845-850.
112. Schroeter, Current status of the potential role of flavonoids in neuroprotection.
Critical reviews of oxidative stress and aging:advances in basic science, diagnostics and intervention. World Scientific Publishing, 2003: p. 137.
113. Peterson, Flavonoids: dietary occurrence and biochemical activity. Nutr. Res., 1998. 18: p. 1995-2018.
114. Burak, Flavonoidler ve antioksidan özellikleri. T. Klin. TıpBilimleri, 1999. 19: p.
296-304.
115. Nijveldt, Flavonoids: a review of probable mechanism of action and potential applications. Clin. Nutr, 2001. 74: p. 418-425.
116. Elliott, The effects of plant flavonoids on mammalian cells: Đmplications for inflammation, heart disease, and cancer. Pharmacological Reviews, 2000. 52: p.
673-751.
117. Kahraman, Protective effect of quercetin on renal ischemia/reperfusion injury in rats. J Nephrol, 2003. 16: p. 219-24.
118. Schroeter H, S.J.P.E., Rice-Evans C, Current status of the potential role of flavonoids in neuroprotection. Critical reviews of oxidative stress and
56
aging:advances in basic science, diagnostics and intervention. World Scientific Publishing, 2003. 1: p. 137.
119. Priya, Protective effect of quercetin in cisplatininduced cell injury in the rat kidney. Indian J. Pharmacol, 1999. 31: p. 422-426.
120. Nakagawa, Differential effects of flavonoid quercetin on oxidative damages induced by hydrophilic and lipophilic radical generator in hepatic Iysosomal fractions of mice. J. Health Science, 2000. 46: p. 509-512.
121. Arivazhagan P, P.S., Panneerselyam C, Effect of DL-alphalipoic acid on the status of lipid peroxidation and lipids in aged rats. J Gerontol A Biol Sci Med Sci., 2003.
58: p. 788-791.
122. Shoenberg MH., B.H., Reperfusion injury after intestinal ischemia. Crit Care Med., 1993. 21: p. 1376-1386.
123. Masella, R., et al., Novel mechanisms of natural antioxidant compounds in biological systems: involvement of glutathione and glutathione-related enzymes. J Nutr Biochem, 2005. 16(10): p. 577-86.
124. Halliwell , B., Free radicals, antioxidants, and human disease: curiosity, cause, or consequence? Lancet, 1994. 344(8924): p. 721-4.
125. Shoskes, D.A., Effect of bioflavonoids quercetin and curcumin on ischemic renal injury: a new class of renoprotective agents. Transplantation, 1998. 66: p. 147-52.
126. Huk, I., Bioflavonoid quercetin scavenges superoxide and increases nitric oxide concentration in ischaemia-reperfusion injury: an experimental study. Br J Surg, 1998. 85: p. 1080-5.
57 T.C.
ERCİYES ÜNİVERSİTESİ
TIP FAKÜLTESİ DEKANLIĞI’NA
Dr. Filiz YILDIZ’a ait “Sıçanlarda Oluşturulan Deneysel İntestinal İskemi Reperfüzyon Modelinde Quercitrin’in Etkileri Üzerine Etkisi” başlıklı tez çalışması jürimiz tarafından Genel Cerrahi Anabilim Dalı’nda Tıpta Uzmanlık Tezi olarak kabul edilmiştir.
Tarih: …/…/……
Başkan : ... ...
Üye : ... ...
Üye : ... ...